Skip To Main Content

Cardiovascular diseases (CVDs) are the leading cause of death globally1

According to the World Health Organization, an estimated 17.9 million people died from CVDs in 2019, representing 32% of all global deaths.1 Of these deaths, 85% were due to myocardial infarction or stroke.1 A CV event is a highly traumatic experience for patients and their families.2 It takes a heavy emotional toll, brings widespread disability and significantly impedes quality of life.3,4

PTE blue heart

The need is clear: the healthcare community must do more to prevent devastating cardiovascular events in high and very high-risk patients that cause personal, societal and economic trauma!

Reducing risk in very high-risk ASCVD patients requires a HOLISTIC APPROACH and control of all modifiable risk factors, including elevated low-density lipoprotein cholesterol (LDL-C).5

Over 4 million deaths were attributed to elevated LDL-C in 2019.6,12 That’s eight deaths per minute, and many of those could be prevented.

Who are the at-risk patients?

prevent-the-event-banner
PREVENT_THE_1st_EVENT

Mission of the healthcare community: to help ASCVD patients avoid the trauma of a 1st event through effective LDL-C control and CV risk reduction.

ASCVD - atherosclerotic cardiovascular disease, LLT - lipid-lowering treatment, LDL-C - low density lipoprotein cholesterol, T2DM - type 2 diabetes mellitus, CAD - coronary artery disease, PAD - peripheral artery disease, TGs - triglycerides, HbA1c - glycated haemoglobin, BMI - body mass index, CTA - computed tomography angiography, PCI - percutaneous coronary intervention

Références

MAT-BE-2401007 v.1.0 12/2024